当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析

康泰生物

(300601)

  

流通市值:168.46亿  总市值:208.98亿
流通股本:9.00亿   总股本:11.17亿

康泰生物(300601)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.38亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益959892.28万元,未分配利润211239.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1412892.48万元,负债453000.20万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,392,061,330.52645,202,778.572,651,715,620.992,018,201,664.48
营业总成本1,293,245,266.49594,453,971.642,301,437,136.571,597,573,808.72
其他经营收益
营业利润1,725,506.2828,137,574.33181,224,375.2341,131,333.85
利润总额-121,922.0126,969,177.44149,936,979.79334,461,343.35
净利润37,600,910.4122,385,110.07201,553,722.8351,075,774.02
每股收益
其他综合收益-95,966.13-56,881.31-90,939.67-137,744.56
综合收益总额37,504,944.2822,328,228.76201,462,783.13350,938,029.46
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计6,091,018,947.576,229,532,545.456,242,288,938.395,850,624,265.74
非流动资产:
非流动资产合计8,037,905,855.328,025,395,103.098,321,425,556.948,664,915,448.75
资产总计14,128,924,802.8914,254,927,648.5414,563,714,495.3314,515,539,714.49
流动负债:
流动负债合计2,287,083,688.212,327,486,213.632,647,146,164.792,618,772,615.83
非流动负债:
非流动负债合计2,242,918,295.632,244,047,248.682,255,542,981.532,187,278,889.28
负债合计4,530,001,983.844,571,533,462.314,902,689,146.324,806,051,505.11
所有者权益(或股东权益):
归属于母公司股东权益合计9,598,953,225.99,683,541,738.339,661,123,922.629,709,508,043.44
股东权益合计9,598,922,819.059,683,394,186.239,661,025,349.019,709,488,209.38
负债和股东权益合计14,128,924,802.8914,254,927,648.5414,563,714,495.3314,515,539,714.49
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,283,499,324.32581,746,831.932,933,618,620.582,027,717,804.92
经营活动现金流出小计1,207,902,571.92628,050,249.912,330,368,915.751,791,512,554.06
经营活动产生的现金流量净额75,596,752.4-46,303,417.98603,249,704.83236,205,250.86
投资活动产生的现金流量:
投资活动现金流入小计867,721,438.3660,089,822.74862,894,399.8758,913,299.43
投资活动现金流出小计869,983,024.59125,315,698.651,419,581,999.181,316,775,185.54
投资活动产生的现金流量净额-2,261,586.23-65,225,875.91-556,687,599.38-557,861,886.11
筹资活动产生的现金流量:
筹资活动现金流入小计39,984,357.7825,584,357.78224,226,982.25214,126,982.25
筹资活动现金流出小计326,019,151.68124,526,138.31,024,984,900.02890,531,896.66
筹资活动产生的现金流量净额-286,034,793.9-98,941,780.52-800,757,917.77-676,404,914.41
汇率变动对现金及现金等价物的影响-205,643.66-62,987.62-60,732.33-186,029.74
现金及现金等价物净增加额-212,905,271.39-210,534,062.03-754,256,544.65-998,247,579.4
期末现金及现金等价物余额203,163,983.06205,535,192.42416,069,254.45172,078,219.7
补充资料:
现金及现金等价物的净增加额-212,905,271.39--754,256,544.65-
最新报告期:2025-08-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投汤然,刘若飞,贺菊颖0.100.260.422025-08-25
华泰证券代雯,张云逸0.410.490.602025-08-24
中国银河程培0.270.370.462025-08-23
中信建投汤然,刘若飞,贺菊颖0.190.340.472025-07-16
中国银河程培0.270.370.462025-07-02
TOP↑